Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study

BACKGROUND: The optimal dose and fractionation scheme of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) remains unclear due to different tolerated liver volumes and degrees of cirrhosis. In this study, we aimed to verify the dose-survival relationship to optimize dose...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Oncol
Main Authors: Su, Ting-Shi, Liu, Qiu-Hua, Zhu, Xiao-Fei, Liang, Ping, Liang, Shi-Xiong, Lai, Lin, Zhou, Ying, Huang, Yong, Cheng, Tao, Li, Le-Qun
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8058965/
https://ncbi.nlm.nih.gov/pubmed/33882972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-021-01778-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados